218 related articles for article (PubMed ID: 32750486)
1. Metabolomic Profile in HFpEF vs HFrEF Patients.
Hage C; Löfgren L; Michopoulos F; Nilsson R; Davidsson P; Kumar C; Ekström M; Eriksson MJ; Lyngå P; Persson B; Wallén H; Gan LM; Persson H; Linde C
J Card Fail; 2020 Dec; 26(12):1050-1059. PubMed ID: 32750486
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic fingerprint of heart failure with preserved ejection fraction.
Zordoky BN; Sung MM; Ezekowitz J; Mandal R; Han B; Bjorndahl TC; Bouatra S; Anderson T; Oudit GY; Wishart DS; Dyck JR;
PLoS One; 2015; 10(5):e0124844. PubMed ID: 26010610
[TBL] [Abstract][Full Text] [Related]
3. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
Packer M
J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
[TBL] [Abstract][Full Text] [Related]
7. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
Saksena S; Slee A; Saad M
J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
[TBL] [Abstract][Full Text] [Related]
8. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
Hahn VS; Petucci C; Kim MS; Bedi KC; Wang H; Mishra S; Koleini N; Yoo EJ; Margulies KB; Arany Z; Kelly DP; Kass DA; Sharma K
Circulation; 2023 Apr; 147(15):1147-1161. PubMed ID: 36856044
[TBL] [Abstract][Full Text] [Related]
9. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
[TBL] [Abstract][Full Text] [Related]
10. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
Slee A; Saad M; Saksena S
J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
[TBL] [Abstract][Full Text] [Related]
11. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
12. [Similarities and differences of myocardial metabolic characteristics between HFpEF and HFrEF mice based on LC-MS/MS metabolomics].
Zhang ZY; Feng XY; Wang ZH; Huang YZ; Yang WB; Zhang WJ; Zhou J; Yuan ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):722-730. PubMed ID: 37460426
[No Abstract] [Full Text] [Related]
13. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
[TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
15. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
16. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
Wong CN; Gui XY; Rabkin SW
Int J Cardiol; 2024 Mar; 399():131657. PubMed ID: 38101703
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
19. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
[TBL] [Abstract][Full Text] [Related]
20. ST2 in heart failure with preserved and reduced ejection fraction.
Najjar E; Faxén UL; Hage C; Donal E; Daubert JC; Linde C; Lund LH
Scand Cardiovasc J; 2019 Feb; 53(1):21-27. PubMed ID: 30776920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
